Related references
Note: Only part of the references are listed.Profiling of Kidney Injury Biomarkers in Patients Receiving Cisplatin: Time-dependent Changes in the Absence of Clinical Nephrotoxicity
B. George et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)
Population Pharmacokinetic-Toxicodynamic Modeling and Simulation of Cisplatin-Induced Acute Renal Injury in Rats: Effect of Dosing Rate on Nephrotoxicity
Keizo Fukushima et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2016)
Urinary kidney injury molecule-1 and monocyte chemotactic protein-1 are noninvasive biomarkers of cisplatin-induced nephrotoxicity in lung cancer patients
Haruka Shinke et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2015)
Subclinical AKI-an emerging syndrome with important consequences
Michael Haase et al.
NATURE REVIEWS NEPHROLOGY (2012)
Evaluation of Novel Renal Biomarkers with a Cisplatin Model of Kidney Injury: Gender and Dosage Differences
M. Pinches et al.
TOXICOLOGIC PATHOLOGY (2012)
Prognostic assessment of estimated glomerular filtration rate by the new Chronic Kidney Disease Epidemiology Collaboration equation in comparison with the Modification of Diet in Renal Disease Study equation
Hicham Skali et al.
AMERICAN HEART JOURNAL (2011)
The Use of Targeted Biomarkers for Chronic Kidney Disease
Prasad Devarajan
ADVANCES IN CHRONIC KIDNEY DISEASE (2010)
Renal biomarker qualification submission: a dialog between the FDA-EMEA and Predictive Safety Testing Consortium
Frank Dieterle et al.
NATURE BIOTECHNOLOGY (2010)
Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies
Vishal S. Vaidya et al.
NATURE BIOTECHNOLOGY (2010)
Accuracy of Neutrophil Gelatinase-Associated Lipocalin (NGAL) in Diagnosis and Prognosis in Acute Kidney Injury: A Systematic Review and Meta-analysis
Michael Haase et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2009)
Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies
N. Pabla et al.
KIDNEY INTERNATIONAL (2008)
A caution regarding rules of thumb for variance inflation factors
Robert M. O'Brien
QUALITY & QUANTITY (2007)
A study of the interactions between carboplatin and blood plasma proteins using size exclusion chromatography coupled to inductively coupled plasma mass spectrometry
Ruimin Xie et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2007)
Pharmacokinetics of cisplatin and relation to nephrotoxicity in paediatric patients
B Erdlenbruch et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2001)
Share Paper
